The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine

Aim : In chronic migraines(CM), the rate of benefiting from medical treatment is relatively low, and it is known that patients use analgesics extensively. Greater occipital nerve (GON) block, have been started to be used in chronic migraine patients who were refractory to treatment. In this study, w...

Full description

Bibliographic Details
Main Authors: Meltem Karacan Gölen, Dilek Yılmaz Okuyan
Format: Article
Language:English
Published: Rabia Yılmaz 2021-11-01
Series:Journal of Contemporary Medicine
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/1833871
_version_ 1827980276565803008
author Meltem Karacan Gölen
Dilek Yılmaz Okuyan
author_facet Meltem Karacan Gölen
Dilek Yılmaz Okuyan
author_sort Meltem Karacan Gölen
collection DOAJ
description Aim : In chronic migraines(CM), the rate of benefiting from medical treatment is relatively low, and it is known that patients use analgesics extensively. Greater occipital nerve (GON) block, have been started to be used in chronic migraine patients who were refractory to treatment. In this study, we aimed to evaluate the headache attack frequency, analgesic use, VAS (Visual Analog Scale) and MIDAS (Migraine Disability Assessment Scale) scores in the 3-month follow-up of patients we had performed a GON block in our clinic for chronic migraine refractory to medical treatment. Materials and Methods: A total of 120 CM patients were included in the study. The number of analgesics used, the number of days with pain, and the VAS and MIDAS scores were recorded before the GON block and at one and three months of treatment. Results: There was a statistically significant (p lt;0.001*) reduction in the number of days with pain, analgesic use, and the VAS and MIDAS scores in the first and third months compared to the pre-treatment baseline values in patients who had undergone a GON block. No significant differences between the first and third months. Conclusion: After the GON block, we noted a significant reduction of headaches and improved quality of life in patients who had been experiencing severe headaches despite medical treatment. The GON block has an exceptionally high benefit rate, might be considered as a treatment option before migraines gain chronicity, patients are not exposed to an excessive medical burden and increased treatment costs.
first_indexed 2024-04-09T21:50:52Z
format Article
id doaj.art-8e45c1ed2bed498a9b97324442b198f4
institution Directory Open Access Journal
issn 2667-7180
language English
last_indexed 2024-04-09T21:50:52Z
publishDate 2021-11-01
publisher Rabia Yılmaz
record_format Article
series Journal of Contemporary Medicine
spelling doaj.art-8e45c1ed2bed498a9b97324442b198f42023-03-24T19:43:22ZengRabia YılmazJournal of Contemporary Medicine2667-71802021-11-0111679980310.16899/jcm.9550171809The Efficacy of Greater Occipital Nerve Block in Patients With Chronic MigraineMeltem Karacan Gölen0Dilek Yılmaz Okuyan1KONYA NUMUNE HASTANESİ( KONYA NUMUNE STATE HOSPITAL)KONYA NUMUNE HASTANESİ( KONYA NUMUNE STATE HOSPITAL)Aim : In chronic migraines(CM), the rate of benefiting from medical treatment is relatively low, and it is known that patients use analgesics extensively. Greater occipital nerve (GON) block, have been started to be used in chronic migraine patients who were refractory to treatment. In this study, we aimed to evaluate the headache attack frequency, analgesic use, VAS (Visual Analog Scale) and MIDAS (Migraine Disability Assessment Scale) scores in the 3-month follow-up of patients we had performed a GON block in our clinic for chronic migraine refractory to medical treatment. Materials and Methods: A total of 120 CM patients were included in the study. The number of analgesics used, the number of days with pain, and the VAS and MIDAS scores were recorded before the GON block and at one and three months of treatment. Results: There was a statistically significant (p lt;0.001*) reduction in the number of days with pain, analgesic use, and the VAS and MIDAS scores in the first and third months compared to the pre-treatment baseline values in patients who had undergone a GON block. No significant differences between the first and third months. Conclusion: After the GON block, we noted a significant reduction of headaches and improved quality of life in patients who had been experiencing severe headaches despite medical treatment. The GON block has an exceptionally high benefit rate, might be considered as a treatment option before migraines gain chronicity, patients are not exposed to an excessive medical burden and increased treatment costs.https://dergipark.org.tr/tr/download/article-file/1833871headachechronic migrainegreater occipital nerve blockbaş ağrısıkronik migrenbüyük oksipital sinir blokajı
spellingShingle Meltem Karacan Gölen
Dilek Yılmaz Okuyan
The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
Journal of Contemporary Medicine
headache
chronic migraine
greater occipital nerve block
baş ağrısı
kronik migren
büyük oksipital sinir blokajı
title The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
title_full The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
title_fullStr The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
title_full_unstemmed The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
title_short The Efficacy of Greater Occipital Nerve Block in Patients With Chronic Migraine
title_sort efficacy of greater occipital nerve block in patients with chronic migraine
topic headache
chronic migraine
greater occipital nerve block
baş ağrısı
kronik migren
büyük oksipital sinir blokajı
url https://dergipark.org.tr/tr/download/article-file/1833871
work_keys_str_mv AT meltemkaracangolen theefficacyofgreateroccipitalnerveblockinpatientswithchronicmigraine
AT dilekyılmazokuyan theefficacyofgreateroccipitalnerveblockinpatientswithchronicmigraine
AT meltemkaracangolen efficacyofgreateroccipitalnerveblockinpatientswithchronicmigraine
AT dilekyılmazokuyan efficacyofgreateroccipitalnerveblockinpatientswithchronicmigraine